Correlation Between Alpha Tau and VistaGen Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alpha Tau and VistaGen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alpha Tau and VistaGen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alpha Tau Medical and VistaGen Therapeutics, you can compare the effects of market volatilities on Alpha Tau and VistaGen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alpha Tau with a short position of VistaGen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alpha Tau and VistaGen Therapeutics.

Diversification Opportunities for Alpha Tau and VistaGen Therapeutics

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Alpha and VistaGen is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Alpha Tau Medical and VistaGen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VistaGen Therapeutics and Alpha Tau is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alpha Tau Medical are associated (or correlated) with VistaGen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VistaGen Therapeutics has no effect on the direction of Alpha Tau i.e., Alpha Tau and VistaGen Therapeutics go up and down completely randomly.

Pair Corralation between Alpha Tau and VistaGen Therapeutics

Given the investment horizon of 90 days Alpha Tau Medical is expected to under-perform the VistaGen Therapeutics. In addition to that, Alpha Tau is 1.12 times more volatile than VistaGen Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. VistaGen Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest  260.00  in VistaGen Therapeutics on December 26, 2024 and sell it today you would earn a total of  19.00  from holding VistaGen Therapeutics or generate 7.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Alpha Tau Medical  vs.  VistaGen Therapeutics

 Performance 
       Timeline  
Alpha Tau Medical 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Alpha Tau Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
VistaGen Therapeutics 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in VistaGen Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, VistaGen Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Alpha Tau and VistaGen Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alpha Tau and VistaGen Therapeutics

The main advantage of trading using opposite Alpha Tau and VistaGen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alpha Tau position performs unexpectedly, VistaGen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will offset losses from the drop in VistaGen Therapeutics' long position.
The idea behind Alpha Tau Medical and VistaGen Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
FinTech Suite
Use AI to screen and filter profitable investment opportunities